Lars Fransecky
7PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 06, 2026
A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.Hartmut Döhner, Daniela Späth, Maral Saadati
|Dec 08, 2025
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial.Anne Sophie Platzbecker, Julia-Annabell Georgi, Jan Moritz Middeke
|Nov 06, 2024
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia.Leo Ruhnke, Marius Bill, Sven Zukunft
|Sep 16, 2024
Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia.Christoph Röllig, Björn Steffen, Christoph Schliemann
|Jul 06, 2022
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy.Kai Rejeski, Andreas Burchert, Gloria Iacoboni
|Apr 29, 2022
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.Hartmut Döhner, Daniela Weber, Julia Krzykalla
Pageof 2
Frequent Collaborators
3 joint publications
Martin Bornhäuser
3 joint publications
Carsten Müller-Tidow
3 joint publications
Katharina S Götze
3 joint publications
Uwe Platzbecker
3 joint publications
Christian Thiede
3 joint publications
Hubert Serve
3 joint publications
Christoph Röllig
2 joint publications
Axel Benner
2 joint publications
Stefan W Krause
2 joint publications
Tim Sauer
